Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer
Clinical trial NCT06210971 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06210971
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2025-09-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.